Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells

Bioelectromagnetics

Volumn 29, Issue 3, 2008, Pages 169-176

  Girgert, Rainer ^a   Gründker, Carsten ^a   Emons, Günter ^a   Hanf, Volker ^b,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KLINIKUM FÜRTH   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Breast cancer; Coactivators; Corepressors; Gene expression; Tamoxifen resistance

Indexed keywords

CANCER CELLS; CYTOLOGY; DISEASES; ELECTROMAGNETIC FIELDS; POLYMERASE CHAIN REACTION; TUMORS;

BREAST CANCER; BREAST CANCER CELLS; COACTIVATORS; COFACTORS; COREPRESSORS; ESTROGEN RECEPTOR; GENES EXPRESSION; TAMOXIFEN; TAMOXIFEN RESISTANCE; WESTERN SOCIETIES;

GENE EXPRESSION;

TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; GENE EXPRESSION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

EID: 41149180481     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.20387     Document Type: Article

References (17)

1. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
2. Blackman CF, Benane SG, House DE. 2001. The influence of 1.2 microT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth. Bioelectromagnetics 22:122-128.
3. Chan CM, Lykkesfeldt AE, Parker MG, Dowsett M. 1999. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. Clin Cancer Res 5:3460-3467.
4. Davis S, Mirick DK, Stevens RG. 2002. Residential magnetic fields and the risk of breast cancer. Am J Epidemiol 155:446-454.
5. Fleming FJ, Hill AD, McDermott EW, O'Higgins NJ, Young LS. 2004. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J Clin Endocrinol Metab 89:375-383.
6. Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bieche I. 2003. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: Evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin Cancer Res 9:1259-1266.
7. Girgert R, Schimming H, Körner W, Gründker C, Hanf V. 2005. Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields. Biochem Biophys Res Commun 336:1144-1149.
8. Guenther MG, Barak O, Lazar MA. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21:6091-6101.
9. Harland JD, Liburdy RP. 1997. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 18:555-562.
10. Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN. 1995. Use of tamoxifen for breast cancer: Twenty-eight years later. J Clin Oncol 13:513-529.
11. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H. 2000. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin Cancer Res 6:512-518.
12. Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci 95:2920-2925.
13. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Alfred DC, Clark GM, Schiff R. 2003. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95:353-361.
14. Ring A, Dowsett M. 2004. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 11:643-658.
15. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198.
16. Wertheimer N, Leeper E. 1982. Adult cancer related to electrical wires near the home. Int J Epidemiol 11:345-355.
17. Xu L, Glass CK, Rosenfeld MG. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9:140-147.